Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas
- Ingrid H Olsen
- , Jens B Sørensen
- , Birgitte Federspiel
- , Andreas Kjaer
- , Carsten P Hansen
- , Ulrich Knigge
- , Seppo W Langer
71
Citations
(Scopus)